Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jun 2020 |
100 Clinical Results associated with Zhejiang Dongfang Pharmaceutical Co. Ltd. Taiji Group
0 Patents (Medical) associated with Zhejiang Dongfang Pharmaceutical Co. Ltd. Taiji Group
100 Deals associated with Zhejiang Dongfang Pharmaceutical Co. Ltd. Taiji Group
100 Translational Medicine associated with Zhejiang Dongfang Pharmaceutical Co. Ltd. Taiji Group